The effect of exposure to electric fields on EGFR and PDGFR in glioblastoma cell model: In vitro study
Glioblastoma Multiforme (GBM) is recognized as the most common and malignant primary brain tumor, with its aggressive nature largely driven by angiogenesis (new blood vessel formation). A key therapeutic strategy is targeting the Receptor Tyrosine Kinase (RTK) pathway, which frequently involves the highly mutated Epidermal Growth Factor Receptor (EGFR) and Platelet-Derived Growth Factor Receptor (PDGFR). […]

